3.584 to -0.01313, p=0.0482)]. Conclusions: This study shows the difference in enhancement on GE-MRI is much lower in patients with fatty liver and particularly those with liver fibrosis, potentially due to altered hepatocyte uptake of gadoxetic acid. Given the small patient size, specific cut-off values cannot reliably be established. The study also confirms that MR-FF is a reliable modality for the diagnosis of NAFLD, but not liver fibrosis, and that MRE is reliable for the diagnosis of NASH.
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